<DOC>
	<DOCNO>NCT00530972</DOCNO>
	<brief_summary>To determine efficacy safety Peginterfer√≥n alfa-2a ( 40 KD ) plus Ribavirin patient relapse respond previous suboptimal therapy base Interferon .</brief_summary>
	<brief_title>Pilot Study Patients Chronic Hepatitis C Co-infected HIV Patients Relapsers After Previous Therapies</brief_title>
	<detailed_description>An important number co-infected patient treat suboptimally past others ineffective therapy interferon-based . All co-infected patient opportunity retreatment actually therapy .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Male female patient 18 65 year age AntiHCV positive Detectable plasma HCVRNA Relapsers treatment interferon peginterferon +/ ribavirin HIV positive CD4 &gt; /= 200 cell Patients clinically stable liver disease : Hgb &gt; /= 12 g/dL woman 13 g/dL men Leucocytes &gt; /= 3000 mm3 Neutrophil count ( ANC ) &gt; /= 1500 cells/mm3 Platelet count &gt; /= 100.000 cells/mm3 Normal prothrombin , bilirubin , albumin , creatinine uric acid HBsAg negative With antecedent diabetes hypertension necessary previous ocular exploration Women ongoing pregnancy breast feed Positive test screen antiHAV IgM Ab , HBsAg , antiHBc IgM Ab , HBeAg Hemochromatosis Deficit alfa1 antitrypsin Wilson disease Alcoholic liver disease Autoimmune hepatitis Hepatitis toxin exposure Hepatitis obesity Hemoglobinopathy ( e.g . thalassemia ) History evidence bleed esophageal varix condition consistent decompensated liver disease Hepatocarcinoma observe liver ecography . History severe psychiatric disease , especially depression . Severe psychiatric disease define treatment antidepressant medication major tranquilizer therapeutic dos major depression psychosis , respectively , least 3 month previous time history follow : suicidal attempt , hospitalization psychiatric disease , period disability due psychiatric disease History severe seizure disorder current anticonvulsant use History significant cardiac disease could worsen acute anemia ( e.g . NYHA Functional Class III IV , myocardial infarction within 6 month , ventricular tachyarrhythmias require ongoing treatment , unstable angina ) Diabetes Mellitus History immunologically mediate disease ( e.g. , inflammatory bowel disease , idiopathic thrombocytopenic purpura , lupus erythematosus , autoimmune hemolytic anemia , scleroderma , severe psoriasis , rheumatoid arthritis ) History evidence chronic pulmonary disease associate functional limitation Drug use within 6 month 1st dose excessive alcohol consumption . Concomitant treatment ddI Male partner woman pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>co-infected HCV/HIV</keyword>
	<keyword>relapsers</keyword>
</DOC>